HARTFORD, Conn. (February 10, 2022)—CareCentrix, a home-centered care company, announced the addition of Dr. Jonathan Gavras as a senior strategic clinical advisor.
Gavras joins CareCentrix with over 20 years of experience as an innovator in the health care space. He recently served as the president of the Florida market at Bright HealthCare, and was previously the chief medical officer of Florida Blue and served as the president of Guidewell Health—leading the newly formed Guidewell Health independent business unit. In all of his roles Gavras built strong teams focused on driving better outcomes at lower costs for patients, providers and health plans.
“As we drive towards the next phase of CareCentrix’s growth, we are excited about adding Dr. Gavras’ deep understanding of clinical strategy, health plan operations, and pharmacy benefit management to our team,” said CareCentrix CEO John Driscoll. “Additionally, Dr. Gavras brings the unique experience of having been a health plan customer of CareCentrix—which will help our team continuously improve how we serve our plans, providers, and most importantly our patients.”
In addition to Bright HealthCare and Guidewell, Gavras has held other key leadership roles at Prime Therapeutics, Avalon Health and United Healthcare. As part of his role at CareCentrix, he will help build and optimize strategic partnerships as CareCentrix continues to expand access to value-based care in the home.
“CareCentrix is an ideal partner for organizations looking to better manage post-acute and home-based services,” said Gavras. “The company’s focus on patient experience and operational excellence is fundamental to the quality of care that they deliver. I experienced the considerable impact on cost savings and service improvement as a customer. I look forward to helping them continue to expand how we all can empower more health in the home.”
This announcement follows a year of great momentum for CareCentrix as they continued to connect the last mile of care, improving outcomes while lowering the total cost of care for payers. The company has significantly expanded due to the critical need to leverage the home in health care. CareCentrix also released a report conducted by Avalere, a leading, independent health care research and consulting firm, which found that the CareCentrix model of technology-enabled and coordinated whole-person post-acute care lowers the total cost of care by improving outcomes, reducing unnecessary readmissions and keeping patients out of the emergency room.
For more information, visit carecentrix.com.
Thursday, February 10, 2022
